Podcasts about therapeutic

On today's show:  Ukraine the latest Western Fatigue Vancouver Producers created a video series for Alzheimer's treatment called Therapeutic Fibbing The skinny on dose four and rapid testing See omnystudio.com/listener for privacy information.

Dennis Cleary and Rob Ferguson discuss evidence-based treatment strategies and techniques to provide an engaging, motivating, task-oriented, and salient experience providing the requisite use, repetition, and intensity of training for skill acquisition via extended reality (XR). This is part of the Continued Learning Podcast series.

A commentary and discussion on the Spiritual Principle a Day Meditation. Contact Information: 919-675-1058 or facebook.com/groups/theanonpodcast

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Go online to PeerView.com/MWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. With the recent approval of multiple novel therapeutics for patients with bladder cancer, oncology professionals have increased opportunities to improve outcomes in a variety of settings. However, not all patients are being given these promising new treatments. Management protocols often do not include the latest strategies, and clinicians often have several questions about incorporating these new agents, which include bladder-sparing options, immune checkpoint inhibitors, targeted therapies (FGFR inhibitors), and antibody-drug conjugates, into clinical practice. For instance, will the presence of immune-related adverse events (irAEs) in some patients linger after the end of therapy and limit the possible subsequent use of ADCs or FGFR inhibitors? To answer these questions, experts in bladder cancer highlight strategies for optimal care of patients in light of current evidence on and indications for use of immune, targeted, and antibody-based therapies and guidance on safely integrating these agents into treatment plans. Upon completion of this activity, participants should be better able to: Summarize the current roles, mechanisms of action, and key evidence pertaining to novel systemic therapies for patients with localized or metastatic bladder cancer, such as immunotherapies, small molecule targeted therapies, and antibody-drug conjugates, among others, Plan personalized treatment algorithms for patients with localized or metastatic urothelial cancer that incorporate novel and emerging therapies, updated guideline recommendations, and patient-, disease-, and treatment-specific factors, Implement evidence-based strategies and expert recommendations to prevent, mitigate and/or manage treatment-related adverse events that may occur among patients receiving novel systemic therapies for bladder cancer.

Today we welcome Dr. Eva Altobelli, a Santa Monica-based addiction psychiatrist and psychedelics expert who speaks openly about the therapeutic use of psilocybin, ketamine and MDMA. This discussion clarifies both the controversy and the research-based direction the clinical community is moving.

Sometimes, the best therapeutic outlet can be found outside chomping on hay. We're talking horses! Their hard-working nature and calm demeanor gives them the opportunity to serve as a companion in assisting people of all capabilities in achieving their goals.  Lauren Cnare, Executive Director of Three Gaits Therapeutic Horsemanship Center, shares more about the therapeutic riding lessons that Three Gaits offers. She also highlights the awesome horses that are a part of the program.  See omnystudio.com/listener for privacy information.

To forgive is to set a prisoner free and discover that the prisoner was you. - Lewis B. Smedes. In E35 we learned three rules to prevent future emotional scars. But what about past emotional scars? Let's explore how to remove old hurts, grudges, grievances and resentments. The results will be new life and new vitality and a new found peace of mind and happiness. Old emotional scars can't be doctored or medicated. They have to be cut out and completely eradicated. Forgiveness is the way to do this. Therapeutic forgiveness is like surgery. It cuts out, eradicates, cancels and makes the wrong as if it never happened. Anyone can forgive if they are willing. We find it difficult to forgive only because we like our sense of condemnation. We get a perverse and morbid enjoyment out of nursing our wounds. It's important to forgive yourself as well as others. Remorse and regret are attempts to emotionally live in the past Emotions are used correctly and appropriately when they help us respond or react appropriately to some reality in our present environment. You make mistakes. Mistakes don't make YOU. TAGS: IBGR, IBGR Network, Donna Kunde, Londina Cruz, emotional scars, heal emotional scars, how to heal emotional scars, healing the emotional scars, self forgiveness, what is forgiveness, forgiveness meditation, forgiveness, steps to forgiveness, power of forgiveness.

In this hour, Therapeutic Thursday. Pro-life activist Victoria Robinson joins the program to discuss abortion. See omnystudio.com/listener for privacy information.

Julia Aziz, LCSW-S, sheds light on the challenges of managing the role of 'healer' when we ourselves are struggling, and explores the impact of being an actively wounded healer on therapy outcomes.

When was the last time you massaged your guts? And if you're thinking that sounds ridiculous - I agree. The first time I learned about abdominal massage during a yoga training, it seemed absolutely bizarre. But after committing to rolling out my stomach every day for a week, I noticed some changes. My lower back and overall digestion started feeling better (and my core work felt even more efficient). So what changed? Well, it ends up that the fluid in your body (called lymph) also loves a good massage - and abdominal massage is a great way to help it circulate. And while the lymphatic system is usually only brought up in times of illness or infection - keeping your lymph moving can help you move better and feel better overall. In today's episode, you'll learn: The anatomy of the lymphatic system (and why you should care) How movement affects lymphatic draining And how abdominal massage can be a key part of keeping your lymph moving All the links: How to do abdominal Massage [AE Wellness YouTube] A soft massage tool is advantageous for compressing deep soft tissue with low muscle tension: Therapeutic evidence for self-myofascial release Comparison of Manual Lymph Drainage Therapy and Connective Tissue Massage in Women With Fibromyalgia: A Randomized Controlled Trial Mobility Mastery Toolkit - 30 days of mobility workouts for more strength + flexibility Movement Mavens has the tools and strategy to support you on your path to enjoying life without pain - www.aewellness.com/mavens www.aewellness.com/podcast - Show notes, links and more. Join the free Body Nerds FB community: https://www.facebook.com/groups/aewbodynerds/ Come hang out with me on Instagram @hollaformala : https://instagram.com/hollaformala/ TikTok @ aewellness Bodywork Starter Guide - learn the 6 places you need to roll right now for quick relief, plus the reason why what you've tried so far has only given you a temporary fix. Download the guide for free now at www.aewellness.com/bodywork 818-396-6501 is the Body Nerd Hotline - how do you build consistency and/or where are you getting stuck? Drop me a line and let me know your body nerd hacks - you might just hear your voice on a future episode! Today's episode is brought to you by AE Wellness Mobility Assessments. Not sure what you should be doing for mobility? Instead of trying a bazillion things and spending hours a day, get strategic coaching with a Mobility Assessment... with me! You'll get your personalized mobility workout plan with the best mobilizations and activations for you, plus all the videos organized in custom playlists to keep things simple. Save $50 off your Mobility Assessment when you use code BODYNERD at www.aewellness.com/mobility/  

Sex is a tricky subject. Some people like to talk sex but then theres those that think it's something done in private. So we all on the same page Velvet Durags is a "after dark" solocast where Black Madonna deep dives into topics that have to do with Sex, from health to wellness and you might get enlightened on some gadget that can spice up your sex life. On this episode Madonna goes into a deep 'therapeutic' thought about the act of fellatio. Executive Producer: Black MadonnaProducer: Mr.B at The Lion's Den in Jersey City, NJMusic: Streetiebaby- Allis Time Subscribe to our Patreon: https://bit.ly/3zUGGNm Buy Merch: https://goldeneramg.com

In this episode, Joe interviews Dick Simon: Co-Founder and CEO of Sensorium Therapeutics, an organization created to research plants we already know are effective and synthesize new ones. How can we best optimize what we know?  www.psychedelicstoday.com

In this episode, I interview Dr. Irene Luc. A Therapeutic pain specialist. We discuss all things pain but specifically what Fibromyalgia is. Fibro as most call it is a diagnosis for thousands of people, generally more women than men are diagnosed. It's a diagnosis for when people experience widespread pain for no known cause. Most of the time after digging a little deeper, Dr. Luc says there is always an underlying cause. Dr. Luc explains this more in our podcast.She also explains the brain, gut connection as well. Dr Luc uses brain training and her physical therapy approaches to help people get out of pain, anxiety, depression and trauma. She blends modern tech like neurofeedback with compassionate clinical care.Tune in as we discuss this plus other conditions that Dr. Irene has treated.You won't want to miss this episode!!To learn more about Tavia you can go to:healthcoachtavia.com and follow her on IG @healthcoachtavia About Dr. Irene LucDr. Irene started as an artist and found she could be just as creative in medicine as well as on canvas. She has practiced in an orthopedic setting since 2002 with a concentration in treating chronic conditions with pain. Over the last 10 years she extended her studies to the brain and how it processes pain, emotions and trauma which she blended into a new program. She is the only practitioner in Tri-cities, WA and Eastern Washington that is certified in brain training and physical therapy for a holistic approach to pain, anxiety, depression and trauma.Doctorate in Physical Therapy – University of MontanaCertified Therapeutic Pain Specialist (TPS) – EIM/ International Pain and Spine InstituteABPTS Board Certified Orthopedic Clinical Specialist (OCS)Anxiety Certified Rehabilitation Service Provider (A-RSP)Applied Neuroscience and Brain Health Certification – The Neuroscience AcademySexuality Counseling Training – Northwest Institute of IntimacyNeurofeedback User – Brain Trainer InternationalA few more notes about Dr. Irene:Name: Dr. Irene Luc owner/founder Mind Door, LLC : a specialty clinic that blends neuroscience and a hands- on approach to pain and autoimmune conditions Email: info@mind-door.com IG: @burnoutrescue FB: @yourminddoor Website is the most active and has my free program: https://mind-door.com How did you get into this business or what was your inspiration for doing this work? I've always love the human body and understanding it but I was inspired by my grandmother who was a eastern medicine healer to blend both what she taught me with western medicine. I firmly believe that our bodies are designed to heal after I had my first burn out at the age of 22 and my hair fell out. Without a diagnosis but armed with my own understanding of science I Created my own program which is what I share with others today . Learning to live With my own auto immune condition has taught me so much and how to encourage and treat others who might be going through the same. I believe the body has the resources to heal as long as were able to reconnect the brain and body. How long have you been at this career? 20 years!What is your favorite success story? I have so many stories over my career…. One of my clients who have worked with for multiple years Was able to reduce his pain medication by 90% after being in them for almost 15 years and regain his ability to have control over his life and activities. I have another patient where she was in so much pain that the only body part that didn't hurt was the tip of her middle finger. But after working together she was able to run/walk a long distance race! I'm so grateful to be surrounded by amazing patients every sayDo you have a specialty? See above. Mostly I help people reconnect their brain and body is using a blend of neuroscience and eastern medicine.My main focus right now is helping people out of burn out- The physical and mental exhaustion from the pandemic is resulting in people burning out in their health.You can find Dr. Irene at: http://mind-door.comThe Sweet Life Coaching Podcast https://businessinnovatorsradio.com/the-sweet-life-coaching-podcast/Source: https://businessinnovatorsradio.com/ep-34-fibromyalgia-pain-the-brain-body-connection-dr-irene-luc-therapeutic-pain-specialist-with-coach-tavia-morse-salvadalena

To help prepare you for your PM&R Board Exams, we're bringing you a podcast series dedicated to current practices and core knowledge. Main Learning objectives: • Review types of muscle fibers and types of muscle contraction • Define aerobic exercise and physical activity guidelines from the US department of health and human services • Describe the various benefits of cardiovascular exercise, particularly with aging • Understand the physiologic effects of bedrest and immobility Credits: Episode was written and hosted by: Christian Belisario, MD, MS; Katherine Caldwell, MD This episode was reviewed for accuracy by: Franklin Caldera, DO, MBA; Jason Pan, MD This podcast series is directed by: Benjamin Gill, DO, MBA; Rosie Conic, MD, PhD; Sre Gorukanti, MD Please send feedback to aapdigitaloutreach@gmail.com so we can best suit your learning needs! Content for this series is based off of current PM&R learning materials and is created by residents for residents. It is not an official board review study guide.

The third Monday of the month is dedicated to studies in scarring alopecia.   LICHEN PLANOPILARIS   Kahjoogh et al (starts at 5:34). Efficacy, safety, tolerability and satisfaction of N-acetylcysteine and pentoxifylline in lichen planopilaris patients under treatment with topical clobetasol: a triple arm blinded randomized controlled trial. Dermatol Ther. 2022 Jun 15   HYDROXYCHLOROQUINE Beatriz Samões et al (starts at 24:05). Hydroxychloroquine induced melanosis. Reumatol Clin (Engl Ed). Jun-Jul 2022;18(6):377-378.     LINEAR SCLERODERMA de Marsillac P et al (starts at 27:53). Clinical, epidemiological, trichoscopic and histopathological features of linear morphea on the scalp. J Eur Acad Dermatol Venereol. 2022 Jun 13. doi: 10.1111/jdv.18323. Online ahead of print   Ulc E et al (starts at 40:40). Therapeutic and Reconstructive Management Options in Scleroderma (Morphea) en Coup de Sabre in Children and Adults. A Systematic Literature Review. J Clin Med.     DISSECTING CELLULITIS   Melo DF et al (starts at 42:41). Dissecting cellulitis in women: a retrospective multicenter study with 17 patients. Int J Dermatol. 2022 May 15. doi: 10.1111/ijd.16271. Online ahead of print. May;86(5):e207-e208. Ward N et al (starts at 48:03). Dissecting cellulitis of the scalp associated with peripheral and axial spondyloarthritis: report of a case and review of the literature. Clin Rheumatol 2022 Apr 23.

This Refugee Week, we are joined by Dr. Hayley Rajpal to explore the challenges of therapeutic engagement with unaccompanied asylum-seeking minors.

On this episode we talked about:People pleasing, why it happens, and how to work on these behaviorsPeople pleasing Vs. being kindCommon boundary challenges that many folks experienceWhy boundary setting can be hard and how to work on setting better boundariesTangible ways to set boundaries in work and your personal lifeSaying "I'm sorry" and ways to say it differentlyThe challenges impacting millennial women today Find Laura on socials!instagram.com/laurasgrolcswor connect with her for therapy, workshops, or speaking engagementswww.lauragrolcsw.comCheck us out on socials!Instagram @dopeshttherapypodTik Tok @dopeshttherapypodemail us at dopeshttherapypod@gmail.comLogo artwork by Peach and Bean Studio instagram.com/peachandbeanstudio***Disclaimer***Dope Sh*t My Therapist Says Podcast is not a replacement for therapy. The conversations, guests, and tips talked about on the episodes are provided as educational, thought provoking, and to be inspiring and are NOT specific theraputic advice. The views of our guests reflect their own personal experiences and perspectives. Information and tips heard on the episodes are to be used at your own caution and discretion as they are not being given by a therapist that knows you personally. As always please seek out your own individual mental health care to best serve you.

On this week's SciFiles, your hosts Chelsie and Daniel interview Zach Miller. A therapeutic window is a dose range between the minimum effective drug dose (MED) to the minimum toxic drug dose (MTD). Many commonly-used cancer drugs, including chemotherapies such as Doxorubicin, are highly toxic to normal tissues and have narrow therapeutic windows. The drug concentration should constantly remain between the MED and MTD in order to produce risk-free therapeutic effects. In general, critically, administration of too much drug (above the therapeutic window) will cause serious side effects on normal human organs, leading to patient morbidity or even death. On the other hand, too little drug (below the therapeutic window) will result in a lack of treatment efficacy and may induce cancer drug resistance, which is the most important reason for the failure of chemotherapy. Herein, we studied the viability of two cell lines, a dox-sensitive cell line (BT459) and a non-dox-sensitive cell line (4T1), to estimate the therapeutic window of doxorubicin. We studied the cell viability to estimate the therapeutic window of DOX in vitro so as to guide the DOX dose in vivo.If you're interested in talking about your MSU research on the radio or nominating a student, please email Chelsie and Danny at scifiles89fm@gmail.com. Check The Sci-Files out on Twitter, Facebook, Instagram, LinkedIn, and YouTube! 

Michael Alcée, Ph.D. is a clinical psychologist in private practice in Tarrytown, NY and Mental Health Educator at Manhattan School of Music. He specializes in the psychology of artists and everyday creativity and the professional development of therapists. Today we talk with Michael about his book "Therapeutic Improvisation: How to Stop Winging It and Own It as a Therapist". You can find Michael's book at Norton https://wwnorton.com/books/9781324019596   Thanks for listening! Support us by becoming a subscriber to The Science of Psychotherapy Academy! Or you can simply buy us a cup of coffee! Please leave a review! (Reviews are fabulously important to us! On your podcast player you should find an option to review at the bottom of the main page for the podcast - after the list of available episodes) - Here's a link for iTunes. And please subscribe to our show!  You can also find our podcast at: The Science of Psychotherapy Podcast Homepage If you want more great science of Psychotherapy please visit our website thescienceofpsychotherapy.com Grab a copy of our latest book! The Practitioner's Guide to the Science of Psychotherapy

Mike Matthews discusses ways to fight the Internet behemoths and chats with special guest Lovely Lady Friend about great vacation ideas. Join Mike as he podcasts live from Cafe Anyway with Chely Shoehart, Floyd the Floorman, and John Deer the Engineer. Next show it's Benita, the Disgruntled Fiddle Player, and the Brewmaster.

Thick, viscous blood is linked with heart disease development and blood clots. Learn how to assess your blood viscosity and ways to reduce it. Support Healthy Hydration and Exercise Performance with this new Electrolyte Stix by MYOXCIENCE Nutrition: https://bit.ly/3uAWrV6 Blood work cheat sheet: https://bit.ly/3dyy4zM Link to research and show notes: https://bit.ly/blood-viscosity-tips Time Stamps:  00:05 Therapeutic phlebotomy may benefit high ferritin and hemoglobin in men and in post-menopausal women. 00:30 Donating blood once or twice a year brings down stored iron. 00:35 Iron overload and iron excess can drive the process of cardiovascular disease.  01:35 Iron depletion by phlebotomy improves insulin resistance in patients with non-alcoholic fatty liver disease. 01:45 Insulin and hyperinsulinemia cause changes in iron metabolism, iron absorption and iron physiology, and ferritin metabolism. 02:41 Excess iron gets stored in your liver, pancreas, and heart, and can impact your brain.  03:35 More than diet influences iron levels.  06:00 You need iron to transport oxygen in your hemoglobin.  07:18 Iron and ferritin are acute phase reactants.  08:45 COVID 19, even the omicron variant, may increase blood viscosity/thickness.  09:35 Free iron accelerates the process of the oxidation of LDL.  11:15 Ferritin stores iron. It is amino acids that hold molecules of iron. 12:50 Exercise helps with iron metabolism and your cardiovascular system.  14:15 High ferritin and high hemoglobin and hematocrit mean that there is a lot of free iron floating around.  17:50 Phlebotomy therapy for study participants with non-alcoholic fatty liver disease showed improvements in ferritin, hemoglobin, liver enzymes and markers of insulin sensitivity.  21:40 High frequency blood donation is protective against cardiovascular disease and reduced relative risk of having a heart attack.   

Today Greg Lehman is here so we're Chewing Over a recent disagreement he and I had on twitter about TUS (of all things!?). Greg responded to a tweet of mine where I was implying that the proliferation of TUS machines is a sign of regress rather than progress. He seemed to disagree? Or did he. Let's chew it over! Your lunchtime show 12:30-13:00 on Mondays and Fridays with Jack Chew chatting about whatever is topical. Usually healthcare and education, occasionally current affairs, always honest.

EPISODE 1: “Sharing Stories, Sharing Lives" n this episode, CASCW's Permanency and Adoption Competency Certificate (PACC) Program Coordinator Keely Vandre talks with Kendra Morris Jacobson about the history and state of the research around Lifebooks and Lifestory work, and how this framework can be more accessible for integration into child welfare practice. Kendra oversees the Oregon Post Adoption Resource Center (ORPARC) and the Oregon Adoption Resource Exchange (OARE), and is Certified in Therapeutic Life Story Work (TLSWi). In previous clinical work at Oregon Health & Science University, Kendra counseled children and families, led groups and contributed to research projects. Kendra obtained her B.A. in English Literature at Gettysburg College, and M.A. in Counseling Psychology at Lewis & Clark College. She was a supporting contributor to Dr. Redmond Ream's recently published article in Adoption Quarterly, titled “Lifebooks in Child Welfare: Why Isn't a Great Idea Used More Often?”. Visit http://cascw.umn.edu/podcasts for resources and references

The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. Pharmacists will be provided with a view of the landscape of nanomedicines, critical research gaps and implications for patient-safety and therapeutic efficacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The association between music and medicine has been discussed for decades, and the development of music therapy has been shown to improve outcomes for patients of all ages, and from the immune system to the mind. To tell us more about how music can play a role in digital therapeutics, we hear from Brian Harris, the Co-founder and CEO of MedRhythms. MedRhythms is a digital therapeutics company focused on the intersection music, neuroscience and technology. They understand that millions of people live with persistent walking deficits due to injury or disease, and, to address the needs of this patient population, MedRhythms is building the world's first prescription music platform. Thanks to MedRhythms' partnership with Universal Music Group, they provide patients with therapy via music that they know and enjoy. This enables their digital therapeutics to use music content that is curated and screened via a patented process, which carefully selects and customizes interventions to each user. Tune in for an interesting discussion that will make you want to sit up and hear the music! Topics covered: The genesis of MedRhythms - why it all started and going from hospital to home. How music can be used to improve walking following neurologic disease and injury  Evidence generation and how it is evolving Why MedRhythms decided to go the route of a PDT (Prescription Digital Therapeutic) rather than a consumer route Let's talk DTx business: what was the MedRythms original business hypothesis, and how did it change over time? Can you talk about pricing at all?  If you were to dissect your deal with Biogen, what is your business hypothesis on how this partnership will make you both money ? MedRhythms partnership with Universal Music Group, and what it means to users and much more! Guest Links and Resources: Connect with Brian Harris on LinkedIn | Twitter Visit MedRhythms, Inc. Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Welcome to another episode of Hope For Wives. Today we are discussing therapeutic separation otherwise known as a healing separation. What are some myths about therapeutic or healing separation? In your personal story, what role did therapeutic separation play, if any? What are some practical thoughts or suggestions for our listeners in regards to therapeutic separation? How can we offer hope to our listeners when it comes to therapeutic separation? Recovered Peace (Pam Blizzard) - Boundaries Group Hope Redefined (Lyschel Burket) - Online Support Strong Wives (Bonny Burns) -  To be notified of the next open registration for, "Reclaim Your Sexual Identity after Betrayal," email bonny@strongwives.com

Will Willimon is a Professor of the Practice of Christian Ministry at Duke Divinity School and joins us for our series, Bait & Switch: The State of Pastors and How Ministry Just Changed. Will discusses pastoral ministry and what our roles as pastors genuinely are. We discuss the need for our churches to recover a biblical understanding of pastoral ministry and the dangers of not doing so. In these talks, we can find and work on solutions to better the well-being of our churches and our pastors. Listen now!To learn more, visit our website and follow us on Twitter. You can connect with the EJC community in the Everything Just Changed Facebook Group and share with us what just changed for you. We'd love to hear from you! Don't forget to subscribe to the EJC Newsletter here.

Have you ever heard of Sound Healing? Today's guest, Gabrielle-Jibriel Iman (Healer, Lover, Writer, Messenger and Founder of G3MSTONE Healing) gave an overview that Sound Healing is a form of healing that connects higher frequencies to help you connect with your inner self. But don't let this be the only information you learn, take a listen to the full episode to fully understand this form of healing! You can find more about Gabrielle on her social media handle https://www.instagram.com/g3mhealing/ & website https://g3mhealing.square.site Listen and share with others:) Upcoming Event: 2nd Annual Resilient Tea IE SATURDAY, JUNE 25, 2022 AT 12 PM – 3 PM Regular Registration: $55.00 (4/21/22- 6/1/22) Late Registration: $65.00 (6/2/22-6/22/22) Cash App: $HeyAesha Zelle: 786-718-4630 *Please include the email used on this form in the memo line/description Link to register-https://docs.google.com/forms/d/e/1FAIpQLSctNQkyN9l1OQx2CtX-Ja7YeZ5BqJgpFyaDAHA-KkbSc9Hwjw/viewform BWH healing workbook can be found at: amzn.to/3kpZZF1 Looking for an editor, graphic designer, or any other freelancer check out Fiverr Link: fvrr.co/3xIpVA1 Buy "Healing on the Daily" Glass Mugs: www.bwhpodcast.com/product-page/he…f8-799ecc7033cb Check out BWH website at: www.bwhpodcast.com If you are interested in being a guest, please find form here: linktr.ee/bwh_pod

Mike Matthews discusses the best way to behave on the Internet and the reasons why podcasts are plummeting in popularity. Join Mike as he podcasts live from Cafe Anyway with Madame Rootabega, Valentino, and Bison Bentley. Next show it's Chely Shoehart, Floyd the Floorman, and John Deer the Engineer.

Let's explore the romantic undertones of lithium!

There's a big difference between risky behavior, and taking risks which can be both beneficial, and healthy. What is "therapeutic risk-taking," and how can it best be identified?

CHEST June 2022, Volume 161, Issue 6 David Jimenez, MD, PhD, and Tobias Tritschler, MD, MSc, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss whether therapeutic heparin should be administered to acutely-ill hospitalized patients with COVID-19. DOI: https://doi.org/10.1016/j.chest.2022.01.036 DOI: https://doi.org/10.1016/j.chest.2022.01.037  DOI: https://doi.org/10.1016/j.chest.2022.01.038  DOI: https://doi.org/10.1016/j.chest.2022.01.039 

On this episode...Life updates from Lauren and RyanneWhere we thought we'd be at 30 vs. where we actually areSelf comparison and why it's not necessary in this day and ageSingle at 30 and the ups and downs Positives during year 30 and how to make the most of it in this new decade of lifeSelf-worth and how you don't need to have it all together at 30 Check us out on socials!Instagram @dopeshttherapypodTik Tok @dopeshttherapypodemail us at dopeshttherapypod@gmail.comLogo artwork by Peach and Bean Studio instagram.com/peachandbeanstudio***Disclaimer***Dope Sh*t My Therapist Says Podcast is not a replacement for therapy. The conversations, guests, and tips talked about on the episodes are provided as educational, thought provoking, and to be inspiring and are NOT specific theraputic advice. The views of our guests reflect their own personal experiences and perspectives. Information and tips heard on the episodes are to be used at your own caution and discretion as they are not being given by a therapist that knows you personally. As always please seek out your own individual mental health care to best serve you.

We spoke with Adelina Sanchez, founder of Leafly Therapeutic about massage, how a client sparked an idea, and where she will be in 5-years. Watch a snippet from our interview where she talks about how her favorite client pushed her into business. Support CashColorCannabis Podcast by shopping with our affiliates. Ardent. Use our promo code: CASHCOLORCANNABIS for a 30% discount on your purchase of an Ardent FX or Ardent Nova. Shop here Hemp & Fork is changing the way you look at hemp. Eat your plants. Shop here and pick up some hemp hearts. GoodeKind is a CBD brand that cares about customers and the community. Support their growth. Shop with GoodeKind here For being a listener today, Atlantabis Clothing would like to offer you a discount! Shop atlantabisclothing.com and save 10% off your order when you use promo code: CASHCOLORCANNABIS Want to support the show? You can help keep the CashColorCannabis podcast going with a donation. Drop some change in the tip jar here Support the show (https://www.paypal.me/MehkaKing)

Pastor Nate continues our series on heresies and half truths exposing an unfortunately dominate view known as MTD and how to respond to it with the gospel.

Episode 18 - Bryan Nixon - Therapeutic Fish in Relational Waters   Welcome back and thank you for listening! Before I jump into the content of this episode, I have a request as well as some exciting news to share. My request is, if you enjoy this podcast and have found it to be useful, please consider heading to iTunes and offering a rating. It is super helpful with getting the podcast in front of more people who might enjoy it. Additionally, please consider sharing the podcast with others whom you think might be into it. I would be extremely grateful!     Now for the exciting news! As you may know, for the past 4 years I have been a trainer in the Relationally Focused Psychodynamic Therapy post-grad continuing ed program, which I helped develop with fellow therapists Krista Law, Clarissa Hill, and founder, Dr. Roy Barsness. RFPT for short.    We developed this program because Intuitively we all know that we are formed in relationship, harmed in relationship, and we heal in relationship. As therapists we have followed this intuition into a career path. And Research has clearly shown that in spite of which modality of therapy we are trained in, it is the quality of the relationship between therapist and client that will inevitably determine the outcome and yet our training is most heavily focused on equipping us with tools to use when certain symptoms are presented. We are not often taught how to fully show up in a healing and transformative way within the relationship itself. RFPT exists to do precisely that. Rooted in Relational Psychoanalytic theory, we aim to help therapists deepen their clinical work to move beyond good rapport and techniques into transformational authenticity and presence with their patients. We have created this program to offer a communal and developmental structure to therapists who may find themselves silently wondering if they have what it takes to be a therapist or to those who find that their practice feels flat and stagnant, possibly on the brink of burnout, and are longing for a way to add depth, vibrancy, and vitality to the work they initially felt deeply drawn into. The program has been housed within the Seattle School of Theology and Psychology, which has been a huge source of support and organization for us as we have developed the program and we are grateful. As we prepare to begin our fourth year, I am so excited to announce that this Fall we will be launching a brand new institute named the Contemporary Psychodynamic Institute (CPI) which will become the new home for RFPT! In addition to the RFPT program, CPI will also have a number of additional offerings for therapists who are interested in learning more about Relational Psychodynamic practice, including: workshops and events, a learning library, e-courses, blogs and possibly a podcast of its own. I could not be more excited about what is taking shape, so stay tuned for the upcoming launch of our website! I will most likely be posting updates about this process on my Instagram page: @wiwpodcast If you're a therapist and this is interesting to you, you can also DM me there if you are curious to learn more about CPI & the RFPT program. I think all of this segue's nicely into today's episode, which I am calling Therapeutic Fish in Relational Waters. In this episode I will give an overview of several of the most well known therapeutic methods…aka…the fish. And then I will describe the nature of the water in which all of the fish are swimming, that is the relational dynamics that take shape between every therapist and patient. As I mentioned a minute above, the relationship determines how effective the therapy will be, regardless of which technique is being used. Thank you for tuning in and I hope you enjoy!    Links: Relationally Focused Psychodynamic Therapy (RFPT) - Post-grad continuing education program for psychotherapists that I teach in and mentioned at the start of this episode. If you're a therapist and want to learn more, I'd love to chat with you! Send me an email at: bryan@mindfulcounselinggr.com. Relationally Focused Psychodynamic Therapy (RFPT) is an evidence-based treatment approach with strong roots in depth psychology (particularly contemporary Relational Psychoanalysis), dialogical philosophy, and neuroscience. As of December 2018, the Society for the Advancement of Psychotherapy has set forth policy recommendations that evidence-based therapy relationships and responsiveness be taught as frequently as other evidence-based treatments. (Reference: Norcross, J. C., & Lambert, M. J. (2019). Psychotherapy Relationships that work III. Psychotherapy, 55,4, p. 303-315). The RFPT certificate program is a direct response to these policy recommendations.   Why in the World Podcast on Instagram   Bryan Nixon is a psychotherapist and the founder and clinical director of Mindful Counseling GR in Grand Rapids, MI. He is also a teacher and facilitator in Relationally Focused Psychodynamic Therapy, a post-grad continuing education program for therapists.   

For the social workers, therapists, coaches, clinicians, etc. this one is for you. What you'll learn in this episode: What “therapeutic art” really means and what it is NOT The legitimacy of nonclinical therapeutic art work Why you don't need to worry about whether you are “legitimate enough” to help people creatively

Today, I am blessed to have here with me Martha Tettenborn. She is a Registered Dietitian and certified Primal Health Coach with over 30 years of experience working in various areas of nutrition. Her private health coach practice, The Cancer Doula, promotes a low-carb, whole-food-based approach to disease prevention and cancer symptom management. She has been a featured speaker at the Low Carb Long Weekend Summit and on numerous podcasts. Martha also instructs courses for the Nutrition Network and Udemy on the ketogenic approach to cancer treatment. Martha's book, Hacking Chemo: Using Ketogenic Diet, Therapeutic Fasting and a Kickass Attitude to Power Through Cancer, is now available as an e-book and print-on-demand paperback. It tells her story of the diagnosis and treatment of ovarian cancer and offers strategies and interventions that Martha has found very powerful in helping through this journey that is cancer.In this episode, Martha opens up about her training as a registered dietitian; she was taught that fat was the enemy. Here's What We Cover in this Episode:What Martha Learned As A Registered Dietitian In The Early 1980s About Martha's Cancer Diagnosis and What She Learned About Cancer CellsHow To Put Pressure On Your Cancer Cells Through A Low-Carbohydrate Diet  How Martha Would Use Fasting With Chemo To Stay Healthy How Does Cancer Affect Your Weight Loss or Weight Gain?Remember That Cancer Is Not A Foreign Invader; It Is Your Own CellsCoachingIf you're ready to lose the weight for good, you've come to the right place!Join my online course, Zivli, to learn the science behind weight loss and habit change so you can lose weight, get healthy, and prevent disease. Also included with the program are weekly office hours with me and a membership site for encouragement, accountability, and support from other members. To learn more, go to https://www.zivli.com/join. Free Weight Loss ResourcesWeight Loss Masterclass to Lower Insulin Resistance & InflammationThe 5% Mindset | How to Win at Weight LossThe Ultimate Food Guide | What to Eat to Burn Fat Connect on Social>> Subscribe to My YouTube Channel>> Like My Facebook Page>> Follow Me on Instagram>> Connect on LinkedIn>> View My Website Subscribe & Review in Apple PodcastsAre you subscribed to my podcast? If you're not, I want to encourage you to do that today. I don't want you to miss an episode. Click here to subscribe in Apple Podcasts.Now if you're feeling extra loving, I would be really grateful if you left me a review over on Apple Podcasts, too. Those reviews help other people find my podcast and they're also fun for me to go in and read. Just click here to review, select “Ratings and Reviews” and “Write a Review” and let me know what your favorite part of the podcast is. Thank you!

Soem reading Resources The Mind Body Code by Dr. Mario Martinez The Psychedelic Explorer's Guide: Safe, Therapeutic and Sacred Journeys by James Fadiman The Mind Body Self by Dr. Mario Martinez TIP 57: Trauma-Informed Care in Behavioral Health Services Downloadable from Substance Abuse and Mental Health Services Administration (Click Link Above)  Drug Use for Grown Ups: Chasing Liberty in the Land of Fear by Dr. Carl L. Hart How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression and Transcendence by Michael Pollan Psychedelic Medicine: The Healing Powers of LSD, MDMA, Psilocybin and Ayahuasca by Dr Richard Louis Miller Psychedelics and Psychotherapy: The Healing Potential of Expanded States by Tim Read The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead by Timothy Leary, Ralph Metzner, Richard Alpert

Kink isn't a replacement for therapy, but it can be therapeutic. On Ep 189 Andrea Glik, LMSW explains the impact of trauma on our nervous system, depression as a survival response, the stress response cycle, the difference between glimmers and triggers, how BDSM can be used to heal trauma for both doms and subs, how she integrates clients BDSM experiences into therapy, plus how healing can manifest through CNC, little space, subspace, aftercare, and more. Even if you're not a kinkster, this episode will help you discover how trauma & shame affect your s3xual identity. Also a must-listen for mental health providers and those struggling to get their therapists to understand the importance of kink in their lives.      Andrea Glik Bio Andrea Glik, LMSW is a psychotherapist, somatic healer, and sex educator. Andrea specializes in treating trauma and PTSD for women, survivors, and queer & trans folks, utilizing body-based and feminist therapy practices to help clients come home to themselves. Andrea practices on occupied Lenape territory (colonized as NYC) and can also be found on Instagram @somaticwitch. Episode 189 Links Andrea Glik Instagram https://www.instagram.com/somaticwitch/ Andrea Glik YouTube https://www.youtube.com/channel/UCVUm2ZAxWeu7DrcMRpP1JPw? Andrea Glik website https://www.andreaglik.com/ Healing through BDSM class & https://www.andreaglik.com/post/healing-through-bdsm Other workshops andreaglik.com/shop Inside Eyes Podcast, Healing Sexual Trauma with Psychedelics & Entheogens   https://www.lauramaenorthrup.com/inside-eyes-podcast Burnout, The Secret to Unlocking the Stress Response Cycle by Emily Nagoski https://www.amazon.com/Burnout-Secret-Unlocking-Stress-Cycle/dp/198481706X Waking the Tiger: Healing Trauma by Peter Levine https://www.amazon.com/Waking-Tiger-Healing-Peter-Levine/dp/155643233X Open Deeply Podcast http://opendeeplypodcast.com Sunny Megatron TikTok https://www.tiktok.com/@sunnymegatron Ken's charity DnD game Mondays 4pm-7pm PT https://www.twitch.tv/thunderpantsacademy American Sex Podcast Discord Community http://bit.ly/discordasp American Sex Podcast Patreon http://patreon.com/americansex Kink Academy Online BDSM Learning Library http://bit.ly/kinkacademy Sunny's Free Kink Negotiation & Scene Planning Mini-Workbook https://sunnymegatron.gumroad.com/l/negotiationwb   Episode 189 Sponsor & Affiliate Discount Codes/Links *by using our links & codes you can help support our work while saving a few bucks too—win/win! 30-day free trial of Dipsea Stories when you use code SUNNY http://dipseastories.com/sunny 10% off your first month with BetterHelp http://betterhelp.com/asp 15% off AND free shipping when you go to http://LikeAKitten.com/sunny OR enter code SUNNY at checkout Get up to 2 free months of podcasting service with Libsyn using this link https://signup.libsyn.com/?promo_code=SUNNY or use code SUNNY Hot & Healthy Erotic Humiliation recorded class https://gum.co/humiliationclass Prostate Play for Beginners (recorded class) from Sugar Baltimore https://www.sugartheshop.com/prostate-milking-for-beginners.html Sunny & Ken's classes on Kink Academy http://bit.ly/kinkacademyelectric & http://bit.ly/kinkacademyhumiliation 10% off American Sex Podcast & Sunny Megatron merch with code SUNNY (t-shirts, mugs, phone cases & more) http://bit.ly/sunnyshirts 15% off your order at Lovehoney when you use this link http://bit.ly/lovehoney15 This link can be a little wonky and does not keep tracking cookies. If the discount does not show up in your cart (or disappears after you shop around on the site), access the site with that link again. Your items will still be in your cart & the discount will appear) 15% off everything at Lelo.com with code SUNNY 10% off everything (with minor restrictions) online from woman-owned, feminist, trans & queer-friendly Early To Bed http://bit.ly/sunnyetb with code SUNNY 10% off everything from Fun Factory using this link http://bit.ly/sunnyfunfactory and the code SUNNY at checkout 15% off most items from Stockroom https://bit.ly/sunnystockroom15 with code SUNNY _______________________________________________________________ –Submit your BDSM & sex advice questions by email to americansexpodcast@gmail.com –To support American Sex podcast, please visit http://patreon.com/americansex (plus you'll get all episodes early, secret episodes, bonus stories from guests, on-air shout-outs, stuff in the mail & more!) –Get friendly with us on Twitter at @AmericanSexPod or visit sunnymegatron.com or americansexpodcast.com –Join our mailing list by visiting http://sunnymegatron.com/newsletter Sunny & Ken, xo!

On this week's episode, the staff at Sacred Heart learn how much they changed over the course of a month. In the real world, Joelle is away, Johnny C is back, and one of our favorite fan callers returns.  See omnystudio.com/listener for privacy information.